** Shares of XtalPi Holdings 2228.HK rise 6.2% to HK$6.2, their highest level since March 31
** Drug discovery and intelligent automation solutions provider completes acquisition of UK's Liverpool ChiroChem (LCC) Technologies
** Liverpool ChiroChem designs and synthesises tech research and development of novel molecules, especially new chiral molecules
** XtalPi says acquisition will increase its technical strength in chemical space exploration and improves its ability to serve domestic and international customers
** Hong Kong's healthcare index .HSCIH rises 3.6%, Hang Seng Biotech Index .HSHKBIO surges 3.9%
** YTD, stock up 1%
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。